Adjuvant, intravesical bacillus Calmette–Guérin (BCG) therapy reduces the risk of recurrence and progression of superficial bladder cancer, but confers a considerable risk of local and systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback